Forums › ACCA Forums › ACCA FR Financial Reporting Forums › Specimen paper dec 2014
- This topic has 2 replies, 2 voices, and was last updated 10 years ago by MikeLittle.
- AuthorPosts
- November 23, 2014 at 11:35 am #212378
Dear sir
Could you please explain to me question 4:
Why should we amortise development costs and why should we multiply by 3/12 from march to june?Question 14:
Diluted earnings per share,
How do we get 800,000 shares?November 23, 2014 at 2:03 pm #212416Two months, January and February, are pure research @ 40,000 per month = 80,000
March through June are deferred development costs = 4 * 40,000 deferred
July through September the revenue flows in so we match the benefit of the revenue with the appropriate element of the deferred costs. A full year amortisation would be 160,000 / 5 = 32,000
But the period to the year end is only 3 months so amortisation is 3 / 12 * 32,000 = 8,000
Total costs are therefore 80,000 + 8,000 = 88,000
Incidentally, March to June is FOUR months, not three per your post
November 23, 2014 at 2:05 pm #212418Part 2 of your post:
2 million shares at a cost of $1.20 would raise $2.4 million
If the company had wanted to raise $2.4 million in the year with an issue at full market price, they would have had to issue 800,000 shares
That’s where the 800,000 comes from
- AuthorPosts
- You must be logged in to reply to this topic.